• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Training the synergy between Bacillus Calmette-Guérin and immune checkpoint-blocking antibodies in bladder cancer.

作者信息

Pichler Renate, Thurnher Martin

机构信息

Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.

Immunotherapy Unit, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Cancer Commun (Lond). 2025 Apr;45(4):438-441. doi: 10.1002/cac2.12647. Epub 2025 Jan 10.

DOI:10.1002/cac2.12647
PMID:39797503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11999882/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d2/11999882/1c580f631aac/CAC2-45-438-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d2/11999882/1c580f631aac/CAC2-45-438-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d2/11999882/1c580f631aac/CAC2-45-438-g001.jpg

相似文献

1
Training the synergy between Bacillus Calmette-Guérin and immune checkpoint-blocking antibodies in bladder cancer.卡介苗与免疫检查点阻断抗体在膀胱癌中的协同作用训练
Cancer Commun (Lond). 2025 Apr;45(4):438-441. doi: 10.1002/cac2.12647. Epub 2025 Jan 10.
2
Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.抗白细胞介素-10R1 单克隆抗体增强卡介苗诱导的膀胱癌原位模型小鼠中的 T 辅助型 1 免疫应答和抗肿瘤免疫。
J Urol. 2012 Jun;187(6):2228-35. doi: 10.1016/j.juro.2012.01.030. Epub 2012 Apr 13.
3
Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer.卡介苗无应答非肌肉浸润性膀胱癌的新兴免疫治疗选择。
J Urol. 2019 Dec;202(6):1111-1119. doi: 10.1097/JU.0000000000000297. Epub 2019 May 1.
4
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer.CREST 研究：sasanlimab 联合卡介苗治疗卡介苗初治高危非肌层浸润性膀胱癌患者的 III 期临床研究。
Future Oncol. 2024 May;20(14):891-901. doi: 10.2217/fon-2023-0271. Epub 2024 Jan 8.
5
Combined bacillus Calmette-Guerin and interferon use in superficial bladder cancer.卡介苗与干扰素联合应用于浅表性膀胱癌
Expert Rev Anticancer Ther. 2003 Dec;3(6):809-21. doi: 10.1586/14737140.3.6.809.
6
Clinical and Preclinical Therapies for Bladder Cancer Following Bacillus Calmette-Guérin Failure.卡介苗治疗失败后膀胱癌的临床和临床前治疗方法
J Urol. 2023 Jan;209(1):32-48. doi: 10.1097/JU.0000000000002957. Epub 2022 Sep 6.
7
Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.卡介苗治疗非肌层浸润性膀胱癌患者癌症特异性生存预测模型的构建：一项多中心回顾性研究结果
Jpn J Clin Oncol. 2014 Nov;44(11):1101-8. doi: 10.1093/jjco/hyu119. Epub 2014 Aug 19.
8
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.单剂量即刻化疗联合辅助诱导卡介苗治疗高危非肌层浸润性膀胱癌患者可降低复发和进展风险。
Int J Urol. 2022 Aug;29(8):867-875. doi: 10.1111/iju.14926. Epub 2022 May 16.
9
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.经膀胱内吉西他滨联合 1/3 剂量卡介苗灌注治疗对非肌层浸润性膀胱癌患者生活质量的影响：一项前瞻性、随机、Ⅱ期临床试验的结果。
J Urol. 2013 Sep;190(3):857-62. doi: 10.1016/j.juro.2013.03.097. Epub 2013 Mar 29.
10
T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis.T1 非肌肉浸润性膀胱癌的亚分期与卡介苗治疗失败相关，并可改善诊断时的患者分层。
J Urol. 2021 Mar;205(3):701-708. doi: 10.1097/JU.0000000000001422. Epub 2020 Nov 16.

引用本文的文献

1
Hematopoietic stem cell state and fate in trained immunity.训练免疫中的造血干细胞状态与命运
Cell Commun Signal. 2025 Apr 14;23(1):182. doi: 10.1186/s12964-025-02192-1.

本文引用的文献

1
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update.欧洲泌尿外科学会非肌层浸润性膀胱癌（TaT1和原位癌）指南——2024年指南更新摘要
Eur Urol. 2024 Dec;86(6):531-549. doi: 10.1016/j.eururo.2024.07.027. Epub 2024 Aug 17.
2
Prior Fc receptor activation primes macrophages for increased sensitivity to IgG via long-term and short-term mechanisms.预先的 Fc 受体激活通过长期和短期机制使巨噬细胞对 IgG 更敏感。
Dev Cell. 2024 Nov 4;59(21):2882-2896.e7. doi: 10.1016/j.devcel.2024.07.017. Epub 2024 Aug 12.
3
Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy.
卡介苗诱导治疗后膀胱癌患者循环单核细胞中组蛋白H3三甲基化与早期复发缺失的相关性
Bladder Cancer. 2023 Jun 27;9(2):175-186. doi: 10.3233/BLC-230028. eCollection 2023.
4
Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.全身与局部卡介苗免疫疗法治疗膀胱癌促进抗肿瘤微环境：训练免疫的新作用。
Int J Cancer. 2024 Jul 15;155(2):352-364. doi: 10.1002/ijc.34897. Epub 2024 Mar 14.
5
The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions.抗 CD47 抗体的抗肿瘤活性需要 Fc-FcγR 相互作用。
Cancer Cell. 2023 Dec 11;41(12):2051-2065.e6. doi: 10.1016/j.ccell.2023.10.007. Epub 2023 Nov 16.
6
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2.膀胱癌患者膀胱内注射卡介苗会引发针对 SARS-CoV-2 的固有免疫应答。
Front Immunol. 2023 Jul 13;14:1202157. doi: 10.3389/fimmu.2023.1202157. eCollection 2023.
7
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.度伐利尤单抗联合卡介苗（BCG）或外照射放疗用于卡介苗无反应性非肌层浸润性膀胱癌患者的1期试验：印第安纳癌症研究网络GU16 - 243 ADAPT - 膀胱研究。
Eur Urol. 2023 Jun;83(6):486-494. doi: 10.1016/j.eururo.2023.01.017. Epub 2023 Jan 28.
8
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.BCG 膀胱内灌注治疗非肌层浸润性膀胱癌可诱导获得性免疫，降低呼吸道感染风险。
J Immunother Cancer. 2023 Jan;11(1). doi: 10.1136/jitc-2022-005518.
9
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.训练免疫：降低 SARS-CoV-2 感染易感性和严重程度的工具。
Cell. 2020 May 28;181(5):969-977. doi: 10.1016/j.cell.2020.04.042. Epub 2020 May 4.
10
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.肿瘤相关巨噬细胞的PD-1表达抑制吞噬作用和肿瘤免疫。
Nature. 2017 May 25;545(7655):495-499. doi: 10.1038/nature22396. Epub 2017 May 17.